News

pharmaphorum24m

NICE calls for better care after weight-loss therapy ends

People completing a course of obesity medication, or completing a weight-management programme, need better support to help ...
Proactive Investors47m

Nordisk to downgraded by leading investment bank as growth slows and competition intensifies

UBS has lowered its rating on Novo Nordisk (NYSE:NVO) from 'buy' to 'neutral', slashing the price target to DKK340 from ...